Triangle

Former Wachovia building could become Raleigh tech hub

October 9, 2014

(WRAL TechWire)

Developers will host a media event this morning regarding a 10-story office building in downtown Raleigh where New York-based LRC Opportunity Fund announced an $8 million renovation in January 2013. A website for the 227 Fayetteville Street says the 110,000-square-foot building will provide office space for "small startup businesses and entrepreneurs."

Raleigh-based Red Hat completes $700 million offering

October 9, 2014

(The News & Observer, Raleigh)

Red Hat completed a previously announced sale of $700 million worth of senior convertible notes and plans to use $375 million of the proceeds to repurchase shares of its common stock. The Raleigh-based software company will use another $257 million for general corporate purposes that could include future acquisitions.

NC Bankers Association names new president

October 8, 2014

(The News & Observer, Raleigh)

The N.C. Bankers Association named Peter Gwaltney president and CEO effective Jan. 2. Gwaltney, 51, has been CEO of a Memphis, Tenn.-based foundation for the past seven years and was chief executive of the Louisiana Bankers Association from 1999 to 2006. He replaces Thad Woodard, who has led the Raleigh-based trade group since 1997 and is retiring (Statewide, June).

Raleigh-based CRO files for IPO

October 8, 2014

(The News & Observer, Raleigh)

INC Research hopes to raise as much as $150 million in an initial public offering, securities filings show. The Raleigh-based contract research organization, which employs 5,400 people in 50 countries, plans to use proceeds to pay off debt.

Texas Ebola patient receives Chimerix drug

October 7, 2014

(The News & Observer, Raleigh)

A Liberian man infected with the Ebola virus is being treated with brincidofovir, an experimental drug made by Durham-based Chimerix, at a Dallas hospital. The U.S. Food and Drug Administration approved an emergency request for the drug, which is being tested as a treatment for a variety of viruses.

RDU airport authority offers $2.1 million incentive for international flight

October 7, 2014

(The News & Observer, Raleigh)

Raleigh-Durham Airport Authority said it will offer $2.1 million in first-year incentives to add a new international service − specifically a direct flight to Paris or Frankfurt – and leaders are urging local governments and civic groups to match the investment.

Durham's Argos Therapeutics to hire 236 in expansion

October 6, 2014

(The News & Observer, Raleigh)

Argos Therapeutics will receive up to $9.5 million in state and local incentives to expand its Durham headquarters and add a manufacturing plant. The drug developer will hire 236 people with an average annual salary of $90,725 by 2018. Argos has no drugs on the market, but its experimental cancer treatment is in phase III clinical trials.

Salix calls off Cosmo merger

October 6, 2014

(WRAL TechWire)

Amid rumors of a potential acquisition by Botox-maker Allergan, Raleigh-based Salix Pharmaceuticals has called off its pending $2.7 billion merger with Italy's Cosmo Pharmaceuticals. The drug developer said a tougher U.S. tax policy on moving companies overseas was the reason.

Aseptia co-founder departs company

October 6, 2014

(The News & Observer, Raleigh)

Michael Drozd, CEO and co-founder of Aseptia, which operates a plant in Montgomery County as Wright Foods, left the Raleigh-based company in July shortly after it announced the completion of $28 million in financing. The company, ranked No. 15 on Inc. magazine's 2014 list of the nation's fastest growing private companies, uses technology to lengthen the shelf life of food products without the use of preservatives.

Innovation district unveiled in downtown Durham

October 2, 2014

(The News & Observer, Raleigh)

Developers revealed the first phase of the 1.7 million-square-foot Durham Innovation District on Wednesday. Duke University has already leased the Carmichael Building, part of a former tobacco warehouse that has been renovated into office and laboratory space. The project is being developed by Boston-based Longfellow Real Estate Partners and Durham-based Measurement Inc.

Red Hat plans to sell $700 million in convertible notes

October 2, 2014

(The News & Observer, Raleigh)

Raleigh-based Red Hat plans a $700 million offering of convertible notes that will be sold to institutional investors. The software company plans to use up to $400 million of the proceeds to repurchase shares of its common stock, while the rest of the proceeds could be used for general corporate purposes and potential acquisitions. The company has announced three acquisitions this year.

NC State engineering job fair attracts record crowd

October 1, 2014

(The News & Observer, Raleigh)

A record 373 employers were on hand for the first day of N.C. State University's biannual engineering career fair. About 4,000 job seekers turned out for the event held at the McKimmon Center in Raleigh.

Moore County country club for sale

October 1, 2014

(The Fayetteville Observer)

Seven Lakes Country Club, which has seen its membership decline in recent years, is for sale. The Moore County golf club, opened in 1976, will accept sealed bids until Nov. 6 at noon. General Manager Mike Floyd said the club needs about $3 million to $4 million in repairs.

CRO acquires Singapore company

October 1, 2014

(The News & Observer, Raleigh)

Chiltern has acquired Singapore-based Pacific Clinical Research, allowing the contract research organization to double its presence in the Asia-Pacific region. The United Kingdom-based company acquired Cary-based Ockham in July and has operations in Wilmington.

Announcement planned for Durham redevelopment project

September 30, 2014

(WRAL TechWire)

Developers will unveil plans for the "Durham Innovation District" on Wednesday, a downtown project with 1.7 million square feet of office space plus apartments and retail. The project, which will have an emphasis on life-science companies, is led by Boston-based Longfellow Real Estate Partners and Hank Scherich, founder and president of Durham-based Measurement Inc.

Allergan shareholders urge board to delay decision on Salix acquistion

September 30, 2014

(The News & Observer, Raleigh)

Two of Allergan's largest shareholders sent letters to the company's board advising them against making a deal to acquire Raleigh-based Salix Pharmaceuticals before a Dec. 18 shareholder meeting. The Irvine, Calif.-based company is said to be pursuing the Salix acquisition to fend off a hostile takeover by Canada-based Valeant Pharmaceuticals.

Lenovo to complete acquisition of IBM server unit Wednesday

September 29, 2014

(WRAL TechWire)

About 2,000 Triangle IBM workers will be become Lenovo employees when the computer-maker completes its $2.1 billion acquisition of IBM's low-end server unit on Wednesday. Beijing-based Lenovo, which has its North American headquarters in Morrisville, will move from No. 9 to No. 3 among server manufacturers, behind only Hewlett Packard Co. and Dell Inc. 

Four Oaks Bank names new chief operating officer

September 29, 2014

(The News & Observer, Raleigh)

Four Oaks Bank promoted David Rupp to executive vice president and chief operating officer following the retirement of Clifton Painter. Rupp was senior vice president and strategic project manager at the Johnston County bank since June. Painter, who joined the bank in 1986, will serve as a consultant over the next two years. 

NC's oldest printing companies join together

September 29, 2014

(New Bern Sun Journal)

AlphaGraphics of Downtown Raleigh acquired Commerical Printing Co., a Raleigh-based printing company founded in 1884. AlphaGraphics, now a national franchise and owned by the Andrews family of New Bern for five generations, began as Owen G. Dunn Printing in 1902. Terms were not disclosed. 

LabCorp to buy Raleigh-based LipoScience for $85.3 million

September 26, 2014

(The News & Observer, Raleigh)

LipoScience, a Raleigh-based medical diagnostics company, will be acquired by its largest customer for $85.3 million. Burlington-based LabCorp accounts for about 35% of sales of the company's testing products. LipoScience went public in January 2013 at $9 a share, but hasn't traded above $5.25 a share in the past year.